Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Issued
Ratios

Cogent Biosciences (COGT) Accumulated Depreciation & Amortization (2017 - 2020)

Cogent Biosciences has reported Accumulated Depreciation & Amortization over the past 4 years, most recently at $412000.0 for Q4 2020.

  • Quarterly results put Accumulated Depreciation & Amortization at $412000.0 for Q4 2020, down 91.1% from a year ago — trailing twelve months through Dec 2020 was $412000.0 (down 91.1% YoY), and the annual figure for FY2020 was $412000.0, down 91.1%.
  • Accumulated Depreciation & Amortization for Q4 2020 was $412000.0 at Cogent Biosciences, down from $4.6 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for COGT hit a ceiling of $4.6 million in Q4 2019 and a floor of $412000.0 in Q4 2020.
  • Median Accumulated Depreciation & Amortization over the past 4 years was $2.8 million (2017), compared with a mean of $2.7 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: soared 60.37% in 2018 and later plummeted 91.1% in 2020.
  • Cogent Biosciences' Accumulated Depreciation & Amortization stood at $2.2 million in 2017, then soared by 60.37% to $3.5 million in 2018, then surged by 32.47% to $4.6 million in 2019, then plummeted by 91.1% to $412000.0 in 2020.
  • The last three reported values for Accumulated Depreciation & Amortization were $412000.0 (Q4 2020), $4.6 million (Q4 2019), and $3.5 million (Q4 2018) per Business Quant data.